- Oops!Something went wrong.Please try again later.
Applied received the order from 3Sixty Biopharmaceuticals, its exclusive distributor within Africa.
3Sixty agreed to an upfront binding purchase commitment of a minimum of $3.5 million of Airocide systems over the initial one-year term of the agreement.
"3Sixty's has made a significant commitment to providing its customers with tested and proven solutions that will help reopen economies across Africa. With its scale, infrastructure, and experience, we believe they are the right partner to make the Airocide system a market leader in Africa," said Q Saeed, CEO, Applied.
Price action: AUVI shares are trading lower by 2.27% at $10.33 on the last check Friday.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.